Showing 1041-1050 of 1148 results for "".
- Healthy Diet May Reduce Nonmotor Symptoms of Prodromal Parkinson Diseasehttps://practicalneurology.com/news/healthy-diet-may-reduce-nonmotor-symptoms-of-prodromal-parkinson-disease/2469355/A new study published in the August 19, 2020 online issue of Neurology suggests that eating a healthy diet in midlife may be linked to fewer nonmotor symptoms of Parkinson Disease (PD). In this study, participants who strictly followed specific healthy diets were less likely to ha
- Diet High in Fish and Vegetables May Help Preserve Cognitionhttps://practicalneurology.com/news/diet-high-in-fish-and-vegetables-may-help-preserve-cognition/2469228/Results of a study published in Alzheimer (AD) and Dementia show adherence to the Mediterranean diet (high in vegetables, whole grains, fish, and olive oil) correlates with higher cognitive function. Dietary factors also seem to play a role in slowing cognitive decline. Researchers at the Nationa
- Traumatic Brain Injury Linked to Higher Long-Term Dementia-Related Mortalityhttps://practicalneurology.com/news/traumatic-brain-injury-linked-to-higher-long-term-dementia-related-mortality/2485700/Traumatic brain injury (TBI) was associated with higher long-term all-cause mortality in participants in the Framingham Heart Study (FHS), and the association appeared to be largely attributable to dementia-related mortality, according to a cohort study published in JAMA Network Open. In
- GLP-1 Receptor Agonist Treatment Linked to Lower Stroke and Dementia Risk in Those with Diabetes and Obesityhttps://practicalneurology.com/news/glp-1-receptor-agonist-treatment-linked-to-lower-stroke-and-dementia-risk-in-those-with-diabetes-and-obesity/2475791/Treatment with the glucagon-like peptide 1 (GLP-1) receptor agonists semaglutide and tirzepatide for people with type 2 diabetes and obesity may significantly lower risk of stroke, all-cause mortality, and dementia. The new findings, published in JAMA Network Open, suggest that treatment
- Newly Proposed Diagnostic Criteria for Refractory and Resistant Migrainehttps://practicalneurology.com/news/newly-proposed-diagnostic-criteria-for-refractory-and-resistant-migraine/2475313/The diagnosis of refractory migraine requires the failure of all evidenced-based treatment categories, according to consensus definitions developed by a panel of international headache experts. The new diagnosis criteria, which also include definitions for resistant migraine, probable refractory
- Using a Salt Substitute Associated with Significant Reduction in Stroke and Death in Those with a History of Strokehttps://practicalneurology.com/news/using-a-salt-substitute-associated-with-significant-reduction-in-stroke-and-death-in-those-with-a-history-of-stroke/2473787/Replacing salt with a salt substitute in home cooking may significantly reduce risk of recurrence and all-cause mortality for people who have a history of stroke, according to data published in JAMA Neurology. Findings from a prespecified, secondary subgroup analysis of the China Salt Substitute
- FDA Expands Indication for Brineura To Treat CLN2 Diseasehttps://practicalneurology.com/news/fda-expands-indication-for-brineura-to-treat-cln2-disease/2470546/The Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for Brineura (cerliponase alfa; BioMarin Pharmaceuticals, San Rafael, CA), expanding the medication’s indication to be used as a treatment to slow the loss of ambulation in all children
- 5th Annual “Miles for Migraine” Event Held in Scottsdale to Raise Funds for Migraine and Headache Awareness, Treatment, and Researchhttps://practicalneurology.com/news/5th-annual-miles-for-migraine-event-held-in-scottsdale-to-raise-funds-for-migraine-and-headache-awareness-treatment-and-research/2470343/“Miles for Migraine” hosted its 5th annual 2-mile walk, 5-kilometer run, and Relax Scottsdale Event on November 17 at the 2023 Scottsdale Headache Symposium. The 3 events were held to raise funds for migraine and headache awareness and treatment and research. All funds raised will ben
- Data from Danish MS Registry Study Provide Patterns and Predictors for Conversion from RRMS to SPMShttps://practicalneurology.com/news/data-from-danish-ms-registry-study-provide-patterns-and-predictors-for-conversion-from-rrms-to-spms/2470309/Researchers analyzing data from the Danish Multiple Sclerosis Registry revealed patterns and predictors for conversion from relapsing-remitting multiple sclerosis (RRMS) to secondary progressive multiple sclerosis (SMPS). In all, 21.8% of people with relapsing-remitting multiple sclerosis (RRMS)
- The Joint Commission Recognizes National Board of Physicians and Surgeons as Credentialing Authorityhttps://practicalneurology.com/news/the-joint-commission-recognizes-national-board-of-physicians-and-surgeons-as-credentialing-authority/2469995/The Joint Commission has added the National Board of Physicians and Surgeons (NBPAS) as a Designated Equivalent Source Agency, effective July 1, 2022. The NBPAS now meets all major national accreditation standards for hospitals and health plans including the Nation